SUMMARY A 63-year-old man had a solitary extramedullary plasmacytoma of the conjunctiva for several years with no history of ocular inflammation or systemic abnormalities. Immunoperoxidase staining was consistent with a neoplastic lesion. This is the only well documented such case in the recent literature to the best of our knowledge. This rare condition is contrasted with reactive plasma cell granuloma, a benign inflammatory condition, which comprises most of the cases previously reported as plasmacytomas. Since extraskeletal plasmacytomas may be the first manifestation of multiple myeloma, these patients deserve appropriate diagnostic evaluation and close follow-up.
Plasma cell tumours of the conjunctiva are uncommon. When first described in the early twentieth century they were referred to as plasmacytomas or plasmomas.`8 By today's criteria, however, most of these tumours would not be considered true plasmacytomas (rare neoplastic growths consisting of plasma cells) but benign reactive plasma cell granulomas secondary to inflammation.9"' True plasmacytomas are rare; they occur most frequently in the upper respiratory tract. " An extramedullary plasmacytoma can occur as an isolated lesion or as a manifestation of systemic multiple myeloma. To the best of our knowledge this is the only well documented case of solitary extramedullary plasmacytoma of the conjunctiva in the recent literature.
Case report
A 63-year-old man was first seen by us in September 1978. He had had adult-onset diabetes mellitus for 16 years and was referred by the medical clinic for an ocular examination. He mentioned that he had had a painless 'growth' on his right lower lid for several years and that it had increased only slightly in size. He had also noted decreasing visual acuity in the right eye for a few years. There was no complaint of ocular pain, tenderness, or discharge and no history ofocular inflammation or trauma.
On ophthalmological examination his visual acuity was 6/60 (20/200) in the right eye and 6/24 (20/80) in the left. The middle of the right lower lid was notably swollen. When the lid was everted, a discrete reddishtan mass measuring 16 mm in largest diameter and 8 mm in height was noted on the palpebral conjunctiva. It was firm, not tender, and adherent to lid tissue along the full length of its base (Fig. 1) .
Neither eye showed a papillary or follicular conjunctival reaction. The right upper lid and both left lids appeared normal. There was no bulbar conjunctival injection or discharge, comeal staining, or anterior segment inflammation in either eye. Rubeosis was present in the left eye. Intraocular pressure was 12 mmHg in both eyes. Ophthalmoscopic examination disclosed disc neovascularisation, haemorrhages, and exudates in the posterior pole of both eyes.
After the nature and implications of the patient's problems were explained to him we advised excision of the tumour in the right eye and panretinal photocoagulation for the proliferative retinopathy in both eyes. However, the patient refused any treatment. Then on 16 May 1980 he had a sudden loss of vision in the left eye to 6/75 (20/300). Gonioscopic examination disclosed that rubeosis in the left eye had become more marked and neovasculansation of the angle at the 9-o'clock position was present in both eyes. A vitreous haemorrhage obscured the view of the fundus 450 in the left eye. The lid tumour appeared unchanged, with no evidence of growth. Because of his failing vision the patient then agreed to enter hospital for ophthalmic treatment.
General physical findings included small ulcers over the pretibial areas bilaterally, absent peripheral pulses, grade 2/6 systolic ejection murmur, and peripheral and ulnar neuropathy. There was no lymphadenopathy. Laboratory tests gave moderately raised fasting blood glucose levels which ranged from 140 to 170 mg/100 ml (7-8-9-4 mmol/l). The remainder of his laboratory values were normal; these included white blood cell count of 8x 109/l with a
normal differential count, a haemoglobin of 14-2 g/dl, haematocrit of 40 0%, normal electrolytes, prothrombin time, partial thromboplastin time, chemistry profile, blood urea nitrogen, creatine, and urine analysis. Total protein measured 7-3 g/100 ml (73 g/l) with an albumin of 4-3 g/100 ml (43 g/l). Chest roentgenograms revealed diffuse interstitial markings consistent with early congestive heart failure, which on follow-up roentgenograms had resolved. Electrocardiogram showed normal sinus rhythm and a left bundle branch block. On 22 May 1980 the patient underwent an excisional biopsy of the lesion of the right lower lid. The most likely diagnosis at this time was a granulomatous nodule, such as a reaction to a foreign body. A scleral graft was placed at the base of the wound. Because of persistent corneal staining the graft was later removed and a conjunctival flap was advanced over the base of the wound.
The tumour was a well circumscribed, oval, pale tan, fleshy mass measuring 15 x 16x8 mm. Histologically it consisted of sheets of relatively mature plasma cells with characteristic eccentric nuclei and abundant cytoplasm often containing a paranuclear clear space (Golgi space) (Fig. 2) . No other cells, such as lymphocytes, histiocytes, or any other type, were present. A Wright-stained touch imprint accentuated the spokewheel configuration of the nuclear chromatin (Fig. 2) . Congo red stain for amyloid was negative. Immunoperoxidase staining showed that the plasma cells within the tumour contained cytoplasmic IgM and IgG and lambda light chain only. Electron microscopic examination further confirmed the plasmacytic nature of the neoplastic cells, whose cytoplasm con- tained many parallel strands of rough endoplasmic reticulum (Fig. 3) .
A systemic examination showed no evidence of multiple myeloma. Bone marrow biopsy revealed normocellular bone marrow with no evidence of plasmacytosis. Serum protein electrophoresis was within normal limits, as were the immunoglobin measurements: IgG 1060 mg/100 ml (10-6 g/l) (normal, 700-1500 (7-15 g/l)), IgA 348 mg/100 ml (3 5 g/l) (normal, 55-350 (0 5-3 5 g/l)), IgM 257 mg/100 ml (2-6 g/l) (normal, 50-265 (0-5-2-7 g/l)). 
Discussion
Classification of plasma cell disorders is complex. Azar9 has proposed that plasma cell neoplasms be divided into the following categories: multiple plasma cell myeloma, disseminated nonosteolytic myelomatosis, solitary myeloma, plasma cell leukaemia, lymphoplasmacytic lymphomas, malignant lymphomas with M components, and extraskeletal plasmacytoma. These should be differentiated from benign conditions such as reactive plasmacytoses and plasma cell granulomas. Benign monoclonal and polyclonal gammopathies without evidence of systemic disease can also be included."2 It is important to distinguish among these categories, as the causes, prognoses, and treatments differ. Particularly when confronted with a plasma cell tumour of the conjunctiva a distinction among 3 entities should be made:
(1) manifestation of systemic multiple myeloma, (2) solitary extramedullary (or extraskeletal) plasmacytoma, and (3) plasma cell granuloma.
Multiple myeloma is a systemic disease associated with plasma cell infiltration of bone marrow and usually osteolytic lesions as well as the presence of a monoclonal immunoglobin in serum and/or urine. These patients commonly have anaemia and bone pain, and there may be associated extraskeletal spread of myeloma.
Solitary extramedullary plasmacytomas arise without evidence of solitary myeloma of bone or multiple myeloma. The bone marrow, urine, serum electrophoresis, and haemoglobin are normal at diagnosis of the localised tumour. Abnormal findings with spread of tumour to soft tissue or bone may develop later, at which point the tumour is no longer an independent solitary lesion.9 13-iS Histologically the tumour consists of sheets ofmature plasma cells which may invade surrounding tissue.
A reactive plasma cell granuloma, a benign lesion, is not associated with concurrent or subsequent systemic findings (serum protein abnormalities or bone changes). It is induced by an inciting foreign antigen having produced previous inflammation and is adequately treated by excision. Histologically it is composed not only of mature plasma cells but also of histiocytes, lymphocytes, eosinophils, fibroblasts, and capillary endothelial hyperplasia. The term 'granuloma' has also been used for reactive lesions even in the absence of histiocytes.
Plasma cell tumours of the conjunctiva were reported occasionally in the early twentieth century as 'plasmomas' or 'plasmacytomas.' These cases, however, were documented with inadequate clinical and laboratory evaluations. Most authors believed chronic inflammation to be the cause. 18 In fact most cases occurred in patients with trachoma, and all occurred in endemic trachoma regions. In 1915 Verhoeff and Derby reviewed the literature on plasmacytoma and concluded that 'the evidence at hand points to an inflammatory origin for this condition. The clinical fact that it has occurred frequently in conjunctiva showing evidence ofexisting or previous trachoma points in this direction. ' 
